Evidence map›Paper›PMID 36412717›Full record

ArticleBiomimetics (Basel, Switzerland)2022

Preparation of Novel Nanoformulation to Enhance Efficacy in the Treatment of Cardiovascular Disease.

Santhoshkumar Jayakodi, Hyunjin Kim, Soumya Menon, Venkat Kumar Shanmugam, Inho Choi, Medidi Raja Sekhar, Rakesh Bhaskar, Sung Soo Han

Open access · goldAbstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Biomimetic Nanotechnology Vol. 3.Biomimetics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Santhoshkumar JayakodiDepartment of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Science (SIMATS), Chennai 602105, India.ORCID 0000-0002-6784-8431
Hyunjin KimSchool of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Korea.
Soumya MenonDepartment of Chemistry, Indian Institute of Technology, Roorkee 247667, India.
Venkat Kumar ShanmugamSchool of Bio-Sciences and Technology, Vellore Institute of Technology, Vellore 632014, India.
Inho ChoiDepartment of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea.
Medidi Raja SekharDepartment of Chemistry, College of Natural Sciences, Kebri Dehar University, Korahe Zone, Somali Region, Kebri Dehar 3060, Ethiopia.ORCID 0000-0001-8408-8203
Rakesh BhaskarSchool of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Korea.ORCID 0000-0002-0181-6197
Sung Soo HanSchool of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Korea.
Yeungnam University · KRAmhara Agricultural Research Institute · ETIndian Institute of Technology Roorkee · INSaveetha University · INVellore Institute of Technology University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite many efforts over the last few decades, cardiac-based drug delivery systems are experiencing major problems, such as the effective delivery of the precise amount of a drug. In the current study, an effort has been made to prepare a nano-herbformulation (NHF) to overcome the major problem of conventional intervention. Copper oxide-based NHF was prepared using plant extract of

Indexed as

apoptosiscardiovascular diseaseH9C2 cell linenano herb formulationROS scavenging

Identifiers

PMID36412717
PMCPMC9680419
OpenAlexW4308207478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.